FENNEC PHARMACEUTICALS INC. Total Long-Term Debt
FENNEC PHARMACEUTICALS INC. (FENC) had Total Long-Term Debt of $19.38 million as of 2025-09-30, per its 10-Q filed 2025-11-13.
Financial Statements › Balance Sheet › Liabilities
us-gaap:LongTermDebt · last filed 2025-11-13
- 2025-09-30: Long-term Debt $19.38M.
- 2025-06-30: Long-term Debt $19.36M.
- 2025-03-31: Long-term Debt $19.35M.
- 2024-12-31: Long-term Debt $19.34M.
| Period end | Long-term Debt |
|---|---|
| 2025-09-30 | $19.38M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $19.36M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $19.35M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $19.34M 10-K · filed 2025-03-26 |
| 2024-09-30 | $32.10M 10-Q · filed 2024-11-08 |
| 2024-06-30 | $31.77M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $31.35M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $30.93M 10-K · filed 2024-03-29 |
| 2023-09-30 | $25.64M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $25.39M 10-Q · filed 2023-08-07 |
| 2023-03-31 | $25.14M 10-Q · filed 2023-05-12 |
| 2022-12-31 | $24.90M 10-K · filed 2023-03-29 |
| 2022-09-30 | $24.69M 10-Q · filed 2022-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |